Cite
HARVARD Citation
Benadiba, J. et al. (2017). Iron chelation: an adjuvant therapy to target metabolism, growth and survival of murine PTEN-deficient T lymphoma and human T lymphoblastic leukemia/lymphoma. Leukemia & lymphoma. 58 (6), pp. 1433-1445. [Online].